Real-time enrollment status for this her2+ solid tumors clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06126276 |
| Recruiting Status | Recruiting |
| Condition | HER2+ Solid Tumors |
| Phase | Clinical Trial |
| Target Enrollment | 70 participants |
| Active Locations | 153 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT06126276 is currently recruiting participants. This clinical trial study for her2+ solid tumors is actively seeking new participants at 153 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06126276 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 153 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06126276 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.